ScienceDaily recently featured a study conducted by researchers from the John Innes Centre who used gene-editing advances to “achieve a tenfold increase in the production of super-bug targeting formicamycin antibiotics.” Their work is promising because, under laboratory conditions, superbugs like MRSA do not develop a resistance to formicamycins.

Streptomyces formicae is a strain of bacteria found in the nests of African ants, which use the antibiotic producing bacteria to defend against pathogens. Half of all known antibiotics discovered within the last 60 years are also derived from metabolites of Streptomyces bacteria. However, S. formicae can only produce small quantities of antibiotics, which has presented a challenge in scaling up purification of the metabolite for further study and clinical trials.

In this study, the team of researchers uncovered the roles of three important gene regulators and combined mutations to maximize antibiotic production. Researchers used CRISPR/Cas9 genome editing to add an extra copy of the formicamycin boosting gene (forGF) and to delete the formicamycin repressor gene (forJ). The result was a new strain of S. formicae bacteria that produces ten times more formicamycin antibiotics and allows for the molecules to grow in liquid culture – something that previously had not been achieved and was a barrier to the clinical research of this compound.

Dr. Rebecca Devine, first author, stated “formicamycins are promising and powerful new antibiotics and we have used gene editing to generate a strain which over-produces these molecules. This will allow us to understand how they work and determine if they have the new potential for clinical development.”

By changing their shape, some bacteria can grow more resilient to antibiotics

ScienceDaily recently reported on new research...

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Global burden of bacterial antimicrobial...

Obesity protects against death in severe bacterial infection

According to Science Daily, a new study shows...

Johns Hopkins study shows drones can safely transport large bags of blood

Researchers from Baltimore-based Johns Hopkins...

New approach may give new life to old antibiotic

Medical News Today recently featured a study...

Covid-19 in Europe and New Information on Vaccines

Eric Rubin is the Editor-in-Chief of...

La resistencia a los antibióticos en Tanzania es un problema ambiental

Investigadores de la Universidad Estatal de...

Distribuidor exclusivo.

0